Seung C. Sohn

Array ( [id] => 6644770 [patent_doc_number] => 20100227871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/553574 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7936 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227871.pdf [firstpage_image] =>[orig_patent_app_number] => 12553574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223408 [patent_doc_number] => 20100056622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Methods of Using Ramelteon to Treat Patients Suffering from a Variety of Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 12/549195 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5232 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056622.pdf [firstpage_image] =>[orig_patent_app_number] => 12549195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511428 [patent_doc_number] => 20110257138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'MONOTERPENES FOR TREATING RESPIRATORY TRACT DISEASES, IN PARTICULAR BRONCHOPULMONARY DISEASES' [patent_app_type] => utility [patent_app_number] => 13/062388 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15649 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257138.pdf [firstpage_image] =>[orig_patent_app_number] => 13062388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479853 [patent_doc_number] => 20100041763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Salicylamide derivatives as nicotinic alpha 7 modulators' [patent_app_type] => utility [patent_app_number] => 12/462952 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11391 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041763.pdf [firstpage_image] =>[orig_patent_app_number] => 12462952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214034 [patent_doc_number] => 20110136788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME' [patent_app_type] => utility [patent_app_number] => 13/057465 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 48171 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136788.pdf [firstpage_image] =>[orig_patent_app_number] => 13057465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227565 [patent_doc_number] => 08633233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Methods and compositions for treating anxiety' [patent_app_type] => utility [patent_app_number] => 13/057527 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12745 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13057527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502055 [patent_doc_number] => 20110263719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'POLYMORPHIC FORM OF RASAGILINE MESYLATE' [patent_app_type] => utility [patent_app_number] => 13/056012 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4299 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263719.pdf [firstpage_image] =>[orig_patent_app_number] => 13056012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239292 [patent_doc_number] => 08604084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Method' [patent_app_type] => utility [patent_app_number] => 13/055477 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6074 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545985 [patent_doc_number] => 20100016334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/504149 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13679 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016334.pdf [firstpage_image] =>[orig_patent_app_number] => 12504149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937516 [patent_doc_number] => 20110212948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'TREATMENT OF NEONATE FOALS WITH MELOXICAM' [patent_app_type] => utility [patent_app_number] => 13/062372 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 4964 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212948.pdf [firstpage_image] =>[orig_patent_app_number] => 13062372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097668 [patent_doc_number] => 20110003796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'METHOD FOR THE TREATMENT OF PSYCHIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/497943 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7570 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003796.pdf [firstpage_image] =>[orig_patent_app_number] => 12497943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10882506 [patent_doc_number] => 08906886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder' [patent_app_type] => utility [patent_app_number] => 12/497583 [patent_app_country] => US [patent_app_date] => 2009-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10008 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12497583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496456 [patent_doc_number] => 20090264484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Methods and Medicaments for Administration of Ibuprofen' [patent_app_type] => utility [patent_app_number] => 12/491199 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25442 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264484.pdf [firstpage_image] =>[orig_patent_app_number] => 12491199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496494 [patent_doc_number] => 20090264522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS WITH A LOW DOSE COMBINATION OF ESCITALOPRAM AND BUPROPION' [patent_app_type] => utility [patent_app_number] => 12/489891 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15310 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264522.pdf [firstpage_image] =>[orig_patent_app_number] => 12489891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189938 [patent_doc_number] => 20110172222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Oxazolidinones for the Treatment of Inflammatory Conditions of the Gastrointestinal Tract' [patent_app_type] => utility [patent_app_number] => 13/002427 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7230 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172222.pdf [firstpage_image] =>[orig_patent_app_number] => 13002427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003069 [patent_doc_number] => 20110118254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 13/000791 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3916 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118254.pdf [firstpage_image] =>[orig_patent_app_number] => 13000791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558876 [patent_doc_number] => 20090270453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'ANTI-MANIC EFFECTIVE DOSES OF SERTINDOLE' [patent_app_type] => utility [patent_app_number] => 12/485691 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8120 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270453.pdf [firstpage_image] =>[orig_patent_app_number] => 12485691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5457864 [patent_doc_number] => 20090258016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Substituted imidazole derivatives' [patent_app_type] => utility [patent_app_number] => 12/455798 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50739 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258016.pdf [firstpage_image] =>[orig_patent_app_number] => 12455798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294488 [patent_doc_number] => 08222278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Treatment of attention-deficit/hyperactivity disorder' [patent_app_type] => utility [patent_app_number] => 12/475440 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4897 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12475440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503803 [patent_doc_number] => 08034838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Composition and method for the treatment of neurological disorders' [patent_app_type] => utility [patent_app_number] => 12/474740 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3734 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034838.pdf [firstpage_image] =>[orig_patent_app_number] => 12474740 [rel_patent_id] =>[rel_patent_doc_number] =>)